In vivo toxicity of cationic micelles and liposomes

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 11, Issue 2, 2015, Pages 467-477

  Knudsen, Kristina Bram ^a,b,d   Northeved, Helle ^a   Pramod Kumar, E K ^c   Permin, Anders ^c   Gjetting, Torben ^c   Andresen, Thomas L ^c   Larsen, Steen ^a   Wegener, Karen Malene ^a   Lykkesfeldt, Jens ^b   Jantzen, Kim ^b   Loft, Steffen ^b   Møller, Peter ^b   Roursgaard, Martin ^b  

^a H LUNDBECK A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^d NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

Author keywords

In vivo toxicology; Liposomes; Micelles; Nanocarriers; Nanomedicine

Indexed keywords

BIOCHEMISTRY; BIOLOGICAL ORGANS; GENE EXPRESSION; LIPOSOMES; MEDICAL NANOTECHNOLOGY; MICELLES; TOXICITY;

ANTI-OXIDANT RESPONSE; CATIONIC MICELLES; CLINICAL CHEMISTRY; DOSE-RESPONSE STUDY; HISTOLOGICAL EVALUATION; IN-VIVO; INTRAVENOUS INJECTIONS; NANO-CARRIERS;

DRUG DELIVERY;

ALBUMIN; CALCIUM; CATION; CREATININE; CXCL2 CHEMOKINE; GLYCOSIDASE; HEME OXYGENASE 1; INTERLEUKIN 6; LIPOSOME; MONOCYTE CHEMOTACTIC PROTEIN 1; NANOCARRIER; OXOGUANINE DNA GLYCOSYLASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREA; CCL2 PROTEIN, RAT; CXCL2 PROTEIN, RAT; DNA GLYCOSYLTRANSFERASE; HEME OXYGENASE; HMOX1 PROTEIN, RAT; MICELLE; OGG1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CATIONIC MICELLE; CLINICAL CHEMISTRY; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; DOSE RESPONSE; DRUG DELIVERY SYSTEM; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENOTOXICITY; HEMATOLOGY; HISTOPATHOLOGY; LIMIT OF DETECTION; LIVER; LUNG; MALE; MICELLE; NONHUMAN; ORGAN WEIGHT; RAT; SPLEEN; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE TRANSFER;

RATTUS;

ANIMALS; CATIONS; CHEMOKINE CCL2; CHEMOKINE CXCL2; DNA DAMAGE; DNA GLYCOSYLASES; DRUG DELIVERY SYSTEMS; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; HEME OXYGENASE (DECYCLIZING); LIPOSOMES; LIVER; LUNG; MALE; MICELLES; RATS; SPLEEN;

EID: 84922832406     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2014.08.004     Document Type: Article

References (50)

1. Nel A., Xia T., Madler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311(5761):622-627.
2. Vega-Villa K.R., Takemoto J.K., Yanez J.A., Remsberg C.M., Forrest M.L., Davies N.M. Clinical toxicities of nanocarrier systems. Adv Drug Deliv Rev 2008, 60(8):929-938.
3. Kagan V.E., Bayir H., Shvedova A.A. Nanomedicine and nanotoxicology: two sides of the same coin. Nanomedicine 2005, 1(4):313-316.
4. Donaldson K. Resolving the nanoparticles paradox. Nanomedicine (Lond) 2006, 1(2):229-234.
5. Kaasgaard T., Andresen T.L., Jensen S.S., Holte R.O., Jensen L.T., Jorgensen K. Liposomes containing alkylated methotrexate analogues for phospholipase A(2) mediated tumor targeted drug delivery. Chem Phys Lipids 2009, 157(2):94-103.
6. Schnyder A., Huwyler J. Drug transport to brain with targeted liposomes. NeuroRx 2005, 2(1):99-107.
7. Re F., Gregori M., Masserini M. Nanotechnology for neurodegenerative disorders. Nanomedicine 2012, 8(Suppl. 1):S51-S58.
8. Drummond D.C., Meyer O., Hong K., Kirpotin D.B., Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 1999, 51(4):691-743.
9. Bhaskar S., Tian F., Stoeger T., Kreyling W., de la Fuente J.M., Grazu V., et al. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Part Fibre Toxicol 2010, 7:3.
10. Etheridge M.L., Campbell S.A., Erdman A.G., Haynes C.L., Wolf S.M., McCullough J. The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine 2013, 9(1):1-14.
11. Thomas M., Klibanov A.M. Non-viral gene therapy: polycation-mediated DNA delivery. Appl Microbiol Biotechnol 2003, 62(1):27-34.
12. Andresen T.L., Jensen S.S., Jorgensen K. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Prog Lipid Res 2005, 44(1):68-97.
13. Arias J.L., Clares B., Morales M.E., Gallardo V., Ruiz M.A. Lipid-based drug delivery systems for cancer treatment. Curr Drug Targets 2011, 12(8):1151-1165.
14. Szebeni J., Baranyi L., Savay S., Milosevits J., Bunger R., Laverman P., et al. Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies. J Liposome Res 2002, 12(1-2):165-172.
15. van den Hoven J.M., Nemes R., Metselaar J.M., Nuijen B., Beijnen J.H., Storm G., et al. Complement activation by PEGylated liposomes containing prednisolone. Eur J Pharm Sci 2013, 49(2):265-271.
16. Moghimi S.M., Hunter A.C., Murray J.C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001, 53(2):283-318.
17. Garcia-Garcia E., Andrieux K., Gil S., Couvreur P. Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?. Int J Pharm 2005, 298(2):274-292.
18. Dai Z., Gjetting T., Mattebjerg M.A., Wu C., Andresen T.L. Elucidating the interplay between DNA-condensing and free polycations in gene transfection through a mechanistic study of linear and branched PEI. Biomaterials 2011, 32(33):8626-8634.
19. Hu X., Hu J., Tian J., Ge Z., Zhang G., Luo K., et al. Polyprodrug amphiphiles: hierarchical assemblies for shape-regulated cellular internalization, trafficking, and drug delivery. J Am Chem Soc 2013, 135(46):17617-17629.
20. Pereverzeva E., Treschalin I., Bodyagin D., Maksimenko O., Kreuter J., Gelperina S. Intravenous tolerance of a nanoparticle-based formulation of doxorubicin in healthy rats. Toxicol Lett 2008, 178(1):9-19.
21. Sayes C.M., Reed K.L., Warheit D.B. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci 2007, 97(1):163-180.
22. Moller P., Danielsen P.H., Jantzen K., Roursgaard M., Loft S. Oxidatively damaged DNA in animals exposed to particles. Crit Rev Toxicol 2013, 43(2):96-118.
23. Nel A.E., Madler L., Velegol D., Xia T., Hoek E.M., Somasundaran P., et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 2009, 8(7):543-557.
24. Larsen S.T., Roursgaard M., Jensen K.A., Nielsen G.D. Nano titanium dioxide particles promote allergic sensitization and lung inflammation in mice. Basic Clin Pharmacol Toxicol 2010, 106(2):114-117.
25. Pfaller T., Colognato R., Nelissen I., Favilli F., Casals E., Ooms D., et al. The suitability of different cellular in vitro immunotoxicity and genotoxicity methods for the analysis of nanoparticle-induced events. Nanotoxicology 2010, 4(1):52-72.
26. Shah V., Taratula O., Garbuzenko O.B., Patil M.L., Savla R., Zhang M., et al. Genotoxicity of different nanocarriers: possible modifications for the delivery of nucleic acids. Curr Drug Discov Technol 2013, 10(1):8-15.
27. Gjetting T., Andresen T.L., Christensen C.L., Cramer F., Poulsen T.T., Poulsen H.S. A simple protocol for preparation of a liposomal vesicle with encapsulated plasmid DNA that mediate high accumulation and reporter gene activity in tumor tissue. Results in Pharma Sciences 2011, 1(1):49-56.
28. Forchhammer L., Moller P., Riddervold I.S., Bonlokke J., Massling A., Sigsgaard T., et al. Controlled human wood smoke exposure: oxidative stress, inflammation and microvascular function. Part Fibre Toxicol 2012, 9:7.
29. Danielsen P.H., Loft S., Jacobsen N.R., Jensen K.A., Autrup H., Ravanat J.L., et al. Oxidative stress, inflammation, and DNA damage in rats after intratracheal instillation or oral exposure to ambient air and wood smoke particulate matter. Toxicol Sci 2010, 118(2):574-585.
30. Forchhammer L., Johansson C., Loft S., Moller L., Godschalk R.W., Langie S.A., et al. Variation in the measurement of DNA damage by comet assay measured by the ECVAG inter-laboratory validation trial. Mutagenesis 2010, 25(2):113-123.
31. Gjetting T., Arildsen N.S., Christensen C.L., Poulsen T.T., Roth J.A., Handlos V.N., et al. In vitro and in vivo effects of polyethylene glycol (PEG)-modified lipid in DOTAP/cholesterol-mediated gene transfection. Int J Nanomedicine 2010, 5:371-383.
32. Knudsen K.B., Northeved H., Ek P.K., Permin A., Andresen T.L., Larsen S., et al. Differential toxicological response to positively and negatively charged nanoparticles in the rat brain. Nanotoxicology 2014, 8(7):764-774.
33. Kumar E.K., Almdal K., Andresen T.L. Synthesis and characterization of ratiometric nanosensors for pH quantification: a mixed micelle approach. Chem Commun (Camb) 2012, 48(39):4776-4778.
34. Knudsen K.B., Northeved H., Gjetting T., Permin A., Andresen T.L., Wegener K.M., et al. Biodistribution of rhodamine B fluorescence-labeled cationic nanoparticles in rats. J Nanopart Res 2014, 10.1007/s11051-013-2221-1(16:2221).
35. Cao Y., Jacobsen N.R., Danielsen P.H., Lenz A.G., Stoeger T., Loft S., et al. Vascular effects of multi-walled carbon nanotubes in dyslipidemic ApoE-/- mice and cultured endothelial cells. Toxicol Sci 2014, 138(1):104-116.
36. Donaldson K., Poland C.A., Schins R.P. Possible genotoxic mechanisms of nanoparticles: criteria for improved test strategies. Nanotoxicology 2010, 4:414-420.
37. Borm P.J., Robbins D., Haubold S., Kuhlbusch T., Fissan H., Donaldson K., et al. The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol 2006, 3:11.
38. Hong R.L., Huang C.J., Tseng Y.L., Pang V.F., Chen S.T., Liu J.J., et al. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?. Clin Cancer Res 1999, 5(11):3645-3652.
39. Nakanishi T., Kunisawa J., Hayashi A., Tsutsumi Y., Kubo K., Nakagawa S., et al. Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins. J Control Release 1999, 61(1-2):233-240.
40. Nakanishi T., Kunisawa J., Hayashi A., Tsutsumi Y., Kubo K., Nakagawa S., et al. Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins. Biochem Biophys Res Commun 1997, 240(3):793-797.
41. Soenen S.J., Brisson A.R., De C.M. Addressing the problem of cationic lipid-mediated toxicity: the magnetoliposome model. Biomaterials 2009, 30(22):3691-3701.
42. Dokka S., Toledo D., Shi X., Castranova V., Rojanasakul Y. Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes. Pharm Res 2000, 17(5):521-525.
43. Oberdorster G., Oberdorster E., Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005, 113(7):823-839.
44. Schins R.P., Knaapen A.M. Genotoxicity of poorly soluble particles. Inhal Toxicol 2007, 19(Suppl. 1):189-198.
45. Moghimi S.M., Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 2003, 42(6):463-478.
46. Risom L., Dybdahl M., Moller P., Wallin H., Haug T., Vogel U., et al. Repeated inhalations of diesel exhaust particles and oxidatively damaged DNA in young oxoguanine DNA glycosylase (OGG1) deficient mice. Free Radic Res 2007, 41(2):172-181.
47. Risom L., Dybdahl M., Bornholdt J., Vogel U., Wallin H., Moller P., et al. Oxidative DNA damage and defence gene expression in the mouse lung after short-term exposure to diesel exhaust particles by inhalation. Carcinogenesis 2003, 24(11):1847-1852.
48. Nassimi M., Schleh C., Lauenstein H.D., Hussein R., Hoymann H.G., Koch W., et al. A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung. Eur J Pharm Biopharm 2010, 75(2):107-116.
49. DuBois D.D.E.F. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916, 17:863-871.
50. Gabizon A., Shmeeda H., Barenholz Y. Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies. Clin Pharmacokinet 2003, 42(5):419-436.